Protein phosphorylation and Campylobacter jejuni pathogenesis

蛋白质磷酸化和空肠弯曲菌发病机制

基本信息

  • 批准号:
    10448142
  • 负责人:
  • 金额:
    $ 23.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-04-11 至 2024-03-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT Campylobacter jejuni is a primary bacterial cause of gastroenteritis in the US and throughout the world, with 140 million cases worldwide and 1.3 million cases of C. jejuni gastroenteritis in the US each year. This infection leads to >30,000 deaths annually, primarily in children <5 years old in underdeveloped countries. Most cases of C. jejuni disease are sporadic and result from contaminated food (especially poultry) and exposure to environmental waters. Some C. jejuni infections (~1/1,000) lead to the development of Guillain-Barré Syndrome, the leading cause of acute paralysis in the world, as well as reactive arthritis and other sequelae. Despite the high prevalence of Campylobacter disease and some 40 years of research, the mechanisms by which C. jejuni causes disease remain incompletely understood and severely understudied. Phosphorylation of aspartate residues of bacterial regulatory proteins is a well-known mechanism for mediating changes in gene expression. However, it is increasingly recognized that phosphorylation of proteins at serine/threonine (S/T) residues also modifies protein function. The S/T phosphorylation system uses specific kinases to phosphorylate proteins, and phosphatases to remove the phosphates from S/T residues, in response to environmental signals. Importantly, this occurs in bacterial pathogens, modifying many virulence-associated characteristics. For the first time, our preliminary studies indicate provide new evidence that C. jejuni S/T phosphorylates eight proteins related to the critical pathogenic determinants of motility/chemotaxis, suggesting that S/T phosphorylation modulates C. jejuni virulence. We will define the S/T phosphorylation system in C. jejuni, according to the following hypothesis: Overall Hypothesis: C. jejuni phosphorylates proteins at S/T residues to modulate motility/chemotaxis and related pathogenesis characteristics, by means of novel S/T kinases/phosphatases. We propose a detailed study of protein S/T phosphorylation in C. jejuni, focusing on the mechanism by which the phosphorylation of motility/chemotaxis-related proteins affects their functions, as well as determining the proteins that affect the levels of S/T phosphorylation. We will use a combination of genetic, biochemical, and advanced phosphoproteomics approaches to achieve the goals outlined in these two specific aims: Aim 1. Determine the role of S/T phosphorylation for the function of motility/chemotaxis-related proteins, and Aim 2. Determine the roles of putative S/T kinase/phosphatase proteins in modifying C. jejuni proteins. Together, these will lay the groundwork for our long-term goal of identifying druggable targets to interrupt C. jejuni S/T phosphorylation and interrupting inter-host transmission and pathogenesis in humans.
摘要 空肠弯曲杆菌是美国和全世界胃肠炎的主要细菌原因, 130万例C.空肠肠胃炎在美国每年。这种感染导致 每年有超过30 000人死亡,主要是不发达国家5岁以下的儿童。大多数C. 空肠疾病是散发性,由受污染的食物(特别是家禽)和暴露于环境 沃茨。一些C。空肠感染(约1/1,000)导致发生格林-巴利综合征, 引起急性瘫痪以及反应性关节炎等后遗症。尽管患病率很高, 弯曲杆菌病的机制和大约40年的研究,C。空肠致病 仍然不完全了解和严重不足的研究。 细菌调节蛋白的天冬氨酸残基的磷酸化是一种众所周知的机制, 介导基因表达的变化。然而,人们越来越认识到,蛋白质的磷酸化 在丝氨酸/苏氨酸(S/T)残基处的修饰也改变蛋白质功能。S/T磷酸化系统使用特定的 激酶磷酸化蛋白质,磷酸酶从S/T残基中除去磷酸盐, 环境信号。重要的是,这发生在细菌病原体中,改变了许多与毒力相关的基因。 特色初步研究首次为C.空肠S/T 磷酸化与运动性/趋化性的关键致病决定因素相关的八种蛋白质,表明 S/T磷酸化调节C.空肠毒力我们将在C. 空肠,根据以下假设: 总体假设:C。空肠在S/T残基磷酸化蛋白质以调节运动性/趋化性, 相关的发病机制的特点,通过新的S/T激酶/磷酸酶。 我们提出了一个详细的研究蛋白质S/T磷酸化在C。jejuni,重点是机制, 运动性/趋化性相关蛋白的磷酸化影响其功能,以及决定 影响S/T磷酸化水平的蛋白质。我们将综合运用遗传学、生物化学和 先进的磷酸化蛋白质组学方法,以实现这两个具体目标中概述的目标:目标1。 确定S/T磷酸化对运动/趋化相关蛋白功能的作用,目的2。 确定假定的S/T激酶/磷酸酶蛋白在修饰C.空肠蛋白。所有这些 将为我们的长期目标奠定基础,即确定可药物化的目标,以中断C。空肠S/T 磷酸化并中断人类宿主间传播和发病机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STUART A THOMPSON其他文献

STUART A THOMPSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STUART A THOMPSON', 18)}}的其他基金

Protein phosphorylation and Campylobacter jejuni pathogenesis
蛋白质磷酸化和空肠弯曲菌发病机制
  • 批准号:
    10608212
  • 财政年份:
    2022
  • 资助金额:
    $ 23.1万
  • 项目类别:
Campylobacter jejuni cyclic-di-GMP signaling and pathogenesis
空肠弯曲杆菌环二 GMP 信号传导和发病机制
  • 批准号:
    10043488
  • 财政年份:
    2020
  • 资助金额:
    $ 23.1万
  • 项目类别:
Campylobacter jejuni cyclic-di-GMP signaling and pathogenesis
空肠弯曲杆菌环二 GMP 信号传导和发病机制
  • 批准号:
    10196969
  • 财政年份:
    2020
  • 资助金额:
    $ 23.1万
  • 项目类别:
Coordinated stationary phase control of Campylobacter motility and biofilm
弯曲杆菌运动和生物膜的协调固定相控制
  • 批准号:
    8967554
  • 财政年份:
    2013
  • 资助金额:
    $ 23.1万
  • 项目类别:
Coordinated stationary phase control of Campylobacter motility and biofilm
弯曲杆菌运动和生物膜的协调固定相控制
  • 批准号:
    8632606
  • 财政年份:
    2013
  • 资助金额:
    $ 23.1万
  • 项目类别:
Post-transcriptional regulation of virulence in Campylobacter jejuni
空肠弯曲杆菌毒力的转录后调控
  • 批准号:
    8090964
  • 财政年份:
    2010
  • 资助金额:
    $ 23.1万
  • 项目类别:
Campylobacter jejuni outer membrane protein vaccine
空肠弯曲菌外膜蛋白疫苗
  • 批准号:
    7918687
  • 财政年份:
    2009
  • 资助金额:
    $ 23.1万
  • 项目类别:
Campylobacter jejuni outer membrane protein vaccine
空肠弯曲菌外膜蛋白疫苗
  • 批准号:
    6820110
  • 财政年份:
    2004
  • 资助金额:
    $ 23.1万
  • 项目类别:
Campylobacter jejuni DNA methylation and gene regulation
空肠弯曲杆菌 DNA 甲基化和基因调控
  • 批准号:
    6810686
  • 财政年份:
    2004
  • 资助金额:
    $ 23.1万
  • 项目类别:
Campylobacter jejuni outer membrane protein vaccine
空肠弯曲菌外膜蛋白疫苗
  • 批准号:
    7408540
  • 财政年份:
    2004
  • 资助金额:
    $ 23.1万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了